# Gyre Therapeutics, Inc.: Lenders, Customers and Owners

> US
>
> 3 links from the documents that the companies file and the register of legal entities, as of 2026-11-13. A commitment is the commitment at the date of the agreement.

Page: https://annalist.io/atlas/gyre-therapeutics-inc/

## Customers (3)

| Entity | Figure | Evidence | Documents |
| --- | --- | --- | --- |
| [Sinopharm Group Company Limited](https://annalist.io/atlas/sinopharm-group-company-limited/brief.md) | 51.7% of the revenue of the supplier, fiscal year ended 31 Dec 2025 | Stated | [1] |
| [China Resources Pharmaceutical Group Limited](https://annalist.io/atlas/china-resources-pharmaceutical-group-limited/brief.md) | 13.3% of the revenue of the supplier, fiscal year ended 31 Dec 2025 | Stated | [1] |
| [Shanghai Pharmaceuticals Holding Company Limited](https://annalist.io/atlas/shanghai-pharmaceuticals-holding-company-limited/brief.md) | 11.6% of the revenue of the supplier, fiscal year ended 31 Dec 2025 | Stated | [1] |

## Source Documents

- [1] Form 10-K for the fiscal year ended 31 December 2025, 13 Mar 2026 (https://www.sec.gov/Archives/edgar/data/1124105/000119312526106251/0001193125-26-106251-index.htm)

## Full Data

- [Every link of this entity with its claims (JSON)](https://annalist.io/api/v1/atlas/gyre-therapeutics-inc.json)
- [The map of every entity (JSON)](https://annalist.io/api/v1/atlas.json)
- [Every link in one table (CSV)](https://annalist.io/api/v1/panel/links.csv.gz)

---

Figures come from official filings and are provided as they are, without warranty of accuracy or completeness. They are not investment advice.